What Is Immunoassay and How Analyser Platforms WorkAn immunoassay is a laboratory test that measures a specific analyte by exploiting the binding between an antibody and its target antigen. Automated analyser platforms industrialise that reaction: they pipette sample and reagent, incubate, wash, generate a measurable signal and convert it to a concentration against a calibration curve. For a laboratory buyer, the platform choice drives menu breadth, throughput, staffing, consumable cost and the quality of results across immunology, endocrinology, tumour markers, cardiac and infectious-disease testing.The Measurement PrincipleEvery immunoassay depends on antibody specificity. A capture antibody binds the analyte; a second labelled antibody or a labelled analyte produces a detectable signal proportional to concentration. Two architectures dominate. In a sandwich (immunometric) assay the analyte is trapped between two antibodies, and signal rises with concentration, which suits larger molecules such as thyroid-stimulating hormone or troponin. In a competitive assay the analyte competes with a labelled version for limited antibody sites, and signal falls as concentration rises, which suits small molecules such as steroids and some drugs.The label defines the detection method and much of the performance. Enzyme labels (ELISA) generate a colour or luminescent product; radioisotope labels (the older RIA) are now largely retired on safety grounds; fluorescent labels support time-resolved measurement. Most modern high-throughput analysers use chemiluminescence, where the label emits light through an enzymatic or electrochemical reaction. Chemiluminescent immunoassay (CLIA) and electrochemiluminescence (ECLIA) offer wide dynamic range and very low detection limits, which is why they anchor most hospital immunoassay lines.Platform Sub-types and How They CompareBuyers meet several formats, and the right one depends on volume and setting.Batch and microplate systemsPlate-based ELISA processors run 96-well plates in batches. They are economical for research, screening and lower-volume specialist assays, but they are slower and less suited to urgent single-sample work.Random-access automated analysersThese load samples continuously and run any assay on any sample in any order, using bead or well-based chemiluminescence. They deliver high throughput, short turnaround and STAT prioritisation, making them the standard for busy clinical laboratories.Integrated and consolidated platformsMany suppliers combine immunoassay and clinical chemistry on one track, sharing sample handling and a single interface. Consolidation cuts bench footprint and re-pipetting but ties the laboratory more tightly to one vendor's reagents.Point-of-care immunoassayCartridge or lateral-flow readers bring assays such as troponin, HbA1c or infectious-disease markers to A&E, wards and clinics. They trade menu breadth and cost-per-test for speed and simplicity near the patient.Key Specifications a Buyer Must CheckCompare platforms on measurable criteria, not marketing claims. Assess throughput in tests per hour and realistic time to first result for a STAT sample. Scrutinise the assay menu and confirm every assay you need is available and validated on that instrument, since menu gaps force a second analyser or send-outs. Check analytical sensitivity and functional detection limits for low-level markers, the measuring range and on-board dilution, and precision expressed as coefficient of variation. Confirm sample types and volumes, primary-tube sampling, cap-piercing, and on-board reagent capacity, which governs how often staff intervene. Connectivity matters as much as chemistry: the analyser must talk to your laboratory information system and middleware bidirectionally, ideally following IHE and HL7 or ASTM profiles for orders and results.Standards, Regulation and QualityIn the UK, in vitro diagnostic devices are regulated by the MHRA, and reagents and instruments carry UKCA or CE marking with the relevant IVD conformity assessment. Electrical safety follows the IEC 60601-1 family and, for laboratory equipment specifically, IEC 61010; electromagnetic compatibility falls under IEC 60601-1-2 or the equivalent 61326 series. Laboratories operating these platforms typically work to ISO 15189 for medical laboratory quality and competence, which shapes verification, internal quality control and participation in external quality assessment (EQA) schemes. Confirm the manufacturer supplies traceable calibrators and controls, and that assays are standardised to recognised reference materials where they exist, because harmonisation affects whether results are comparable between sites. Guidance from bodies such as the MHRA and NICE can inform which markers and platforms fit a given service.Calibration, QC and Routine MaintenanceImmunoassay results are only as trustworthy as the calibration behind them. Each assay is calibrated with lot-specific calibrators, and re-calibration is triggered by reagent lot change, defined time intervals or QC drift. Run at least two levels of internal quality control per assay per day and review Levey-Jennings charts and Westgard rules before releasing results. Routine maintenance includes daily probe and wash-station checks, weekly cleaning cycles, and periodic replacement of probes, syringes, lamps or detector components. Preventive maintenance visits, usually one or two per year under contract, keep the analyser inside specification and support ISO 15189 compliance. Budget for the engineer response times your service level demands.Decontamination and Single-use ConsiderationsThese analysers process blood and serum, so they are a biological hazard. Reaction cuvettes and pipette tips are often single-use to eliminate carry-over; where probes are reused, the system relies on validated wash steps, and buyers should understand the documented carry-over rate. Waste streams include liquid biohazard and sharps, which need appropriate disposal routes. Surfaces are decontaminated per manufacturer instruction, and staff follow local infection-control and COSHH assessments for reagents. Factor consumable waste volume into both cost and sustainability planning.Care SettingsLarge random-access platforms sit in hospital core laboratories and hub-and-spoke networks serving multiple sites. Smaller benchtop analysers suit GP-linked laboratories, private clinics and specialist services with a defined menu. Point-of-care readers extend selected assays to emergency departments, cardiology, antenatal clinics and community settings. Some markers also appear in veterinary and research laboratories on dedicated analysers. Match instrument scale to genuine workload; an oversized platform wastes reagent on frequent calibration, while an undersized one bottlenecks at peak. Where a hub-and-spoke network runs several analysers of the same model, harmonised reagent lots and shared QC rules keep results comparable so a patient sampled at different sites can be compared over time.Consumables and Total Cost of OwnershipThe purchase price is a small part of lifetime cost. Reagent packs, calibrators, controls, cuvettes, tips, wash and system fluids, and QC and EQA subscriptions dominate the running budget. Many suppliers use reagent-rental or cost-per-reportable-result models that fold instrument cost into consumable pricing, so compare on a fully loaded price per reportable result at your real volumes, including expected repeats and QC. Reagent shelf life and on-board stability affect wastage, especially for low-volume assays. Include service contract, LIS interface fees, uninterruptible power, water quality and staff training in the TCO.Warranty, Servicing and SparesConfirm warranty length and what it covers, guaranteed engineer response and fix times, and whether cover is on-site. Ask about remote monitoring and diagnostics, availability of spares and consumables over the platform's expected life, and end-of-support dates so you are not left with an orphaned analyser. A managed-service or reagent-rental agreement can bundle maintenance, but read the exit and reagent-exclusivity terms carefully.Procurement ChecklistConfirm the full assay menu you need is validated on the platform, with no gaps forcing send-outs.Verify realistic throughput and STAT time-to-first-result at your peak workload.Check analytical sensitivity, measuring range, on-board dilution and precision (CV) for critical assays.Confirm bidirectional LIS/middleware connectivity using HL7 or ASTM profiles.Require UKCA or CE IVD marking, IEC 61010/60601 electrical safety and traceable calibrators.Model fully loaded cost per reportable result, including QC, EQA, repeats and reagent wastage.Agree service response times, spares availability and end-of-support dates in writing.ConclusionChoosing an immunoassay platform is a decision about menu, throughput, connectivity and lifetime cost as much as chemistry. Weigh sensitivity and precision against reagent economics and service support, and match the instrument to your real workload and care setting. To compare analysers, reagent-rental options and consumables from vetted suppliers, use the MediGear buyers hub or contact the MediGear team, and check current UK guidance from the MHRA before you commit.DisclaimerThis article is for informational purposes only. It is published by MediGear (medigear.uk) for general information and procurement guidance, and is not clinical, diagnostic, treatment, technical, engineering, legal or regulatory advice, nor a product endorsement, guarantee or substitute for professional assessment. MediGear does not provide medical consultations. Buyers should consult their clinical, biomedical, estates and regulatory contacts, and the manufacturer's documentation, and independently verify all specifications, certifications, compatibility and suitability before purchase. Specifications, certifications and availability are correct at the time of publication and may change without notice. MediGear is a medical-equipment distributor and does not sell medicines or pharmaceutical products.
